Mind the Byte

About:

Mind the Byte is a bioinformatics company specializing in computational drug design using a pay-per-use SaaS platform.

Website: http://www.mindthebyte.com/

Twitter/X: Mindthebyte

Top Investors: Crowdcube, ENISA, EASME - EU Executive Agency for SMEs, ICF Capital

Description:

Mind the Byte is a bioinformatics company that develops and provides software for computational drug discovery using Big Data and Machine Learning (AI) approaches. We work with partners on a consultancy basis or offer an easy to use Software as a Service (SaaS) package to allow clients to apply the High-performance computing platform on a flexible pay-per-use basis without investment in hardware or software licenses. Mind the Byte has developed a versatile set of applications using cloud computing which lowers the entry barrier to the technology. Mind the Byte is an Amazon Web Services technology partner - a seal of quality that has only been awarded to five companies in this sector – to ensure security and reliability. The company was founded in 2011 by Alfons Nonell-Canals, a specialist in computer-aided drug design and in large-scale chemical and biological analyses, and has since expanded with an experienced staff. The company is located at the Barcelona Science Park and Copenhagen Bio Science Park.

Total Funding Amount:

759000 EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2011-01-01

Contact Email:

info(AT)mindthebyte.com

Founders:

Alfons Nonell-Canals

Number of Employees:

1-10

Last Funding Date:

2017-07-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai